glp-1 shortage canada news today New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our What happens when demand outpaces

A recent pooled analysis of the LEADER and SUSTAIN-6 studies demonstrated a lower risk for persistent 40% or 50% reduction in eGFR from baseline [32]

An insurer covering a 45-year-old, for example, might shoulder the cost of weight lost medications for a decade or so, but sooner or later, those employees will retire, and their health care costs shift to Medicare

Strategies for breaking through Dose adjustment is the most direct pharmacological approach

It also reduces both the production and effectiveness of GLP-1

Williams, is that the second you remove the tool (GLP-1 medication), you'll go right back to feeling hungry and craving unhealthy foods

Moreover, all included studies were observational in nature, making them susceptible to residual confounding and selection bias